0001144204-14-050192.txt : 20140814
0001144204-14-050192.hdr.sgml : 20140814
20140814161623
ACCESSION NUMBER: 0001144204-14-050192
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20140630
FILED AS OF DATE: 20140814
DATE AS OF CHANGE: 20140814
EFFECTIVENESS DATE: 20140814
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Knoll Capital Management, LP
CENTRAL INDEX KEY: 0001325083
IRS NUMBER: 133476926
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-11424
FILM NUMBER: 141043006
BUSINESS ADDRESS:
STREET 1: 5 EAST 44TH STREET
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-808-7474
MAIL ADDRESS:
STREET 1: 5 EAST 44TH STREET
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001325083
XXXXXXXX
06-30-2014
06-30-2014
false
Knoll Capital Management, LP
5 East 44th Street
12th floor
New York
NY
10017
13F HOLDINGS REPORT
028-11424
N
Fred Knoll
President
646-590-3960
/s/ Fred Knoll
New York
NY
08-14-2014
0
15
224399
INFORMATION TABLE
2
infotable.xml
Newlink Genetics Corp
Com
651511107
2056
77437
SH
SOLE
77437
0
0
Medivation, Inc.
Com
58501N101
175705
2279519
SH
SOLE
2279519
0
0
Keryx Biopharmaceuticals Inc.
Com
492515101
3076
200000
SH
SOLE
200000
0
0
Echo Therapeutics Inc.
Com New
27876L206
62
27430
SH
SOLE
27430
0
0
Ampio Pharmaceuticals Inc.
Com
03209T109
24753
2964401
SH
SOLE
2964401
0
0
Alcobra Ltd
SHS
M2239P109
11892
687000
SH
SOLE
687000
0
0
Inovio Pharmaceuticals Inc.
COM NEW
45773H201
1109
102088
SH
SOLE
102088
0
0
Advaxis Inc.
COM NEW
7624208
709
225000
SH
SOLE
225000
0
0
Advaxis Inc.
W EXP 07/15/201
7624117
115
112500
SH
SOLE
112500
0
0
Synthetic Biologics Inc.
COM
87164U102
2394
1360000
SH
SOLE
1360000
0
0
Northwest Biotherapeutics Inc
COM PAR $0.001
66737P600
1344
200300
SH
SOLE
200300
0
0
Nephrogenex Inc
COMM
640667101
301
50000
SH
SOLE
50000
0
0
Galmed Pharmaceuticals Ltd
SHS
M47238106
633
65000
SH
SOLE
65000
0
0
Celsus Therapeutics Plc
SPONSORED ADR NE
15119A202
78
14155
SH
SOLE
14155
0
0
Provectus Biopharmaceuticals
COM
74373P108
172
200000
SH
SOLE
200000
0
0